Viewing Study NCT03462251


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2026-05-05 @ 10:08 AM
Study NCT ID: NCT03462251
Status: COMPLETED
Last Update Posted: 2023-01-19
First Post: 2018-02-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line
Sponsor:
Organization: